Science Explorer Interactive view Map
City · China

Research in Xinghua

Science Explorer records 1 research institutions in Xinghua, China. The highest-ranked on research quality in 2022–2025 are Regend Therapeutics (China).

Research institutions
1
1 of them ranked worldwide
Research works
80
▲ 1151% vs 2013–17
Top-10% rate, 2022–2025
19.0%
record average 16.5%

A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.

Which research institutions are in Xinghua?

#InstitutionWorksAgainst the largest hereWorld rank
1Regend Therapeutics (China)Company 80 #12,334

By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.

Which keywords describe research in Xinghua?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Tumor Microenvironment and Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy12▲ 27×9 topics
  2. Cancer Immunotherapy10▲ 108×3 topics
  3. Tumor Regression10▲ 153×2 topics
  4. Lymphoma9▲ 94×2 topics
  5. CAR T Cells9▲ 196×1 topic
  6. Chimeric Antigen Receptor9▲ 196×1 topic
  7. Tumor Microenvironment5▲ 20×7 topics
  8. Cancer5▲ 6.4×17 topics
  9. Chemotherapy4▲ 9.6×7 topics
  10. Monoclonal Antibodies3▲ 56×2 topics
  11. Cancer Therapy3▲ 7.9×10 topics
  12. Regulation3▲ 8.3×4 topics
  13. Cell Proliferation3▲ 50×3 topics
  14. Transcriptional Regulation3▲ 27×7 topics
  15. Breast Cancer2▲ 17×3 topics
  16. Stem Cells2▲ 15×5 topics
  17. Immune Checkpoint Blockade2▲ 32×1 topic
  18. Mechanotransduction2▲ 53×2 topics
  19. PD-1 and PD-L12▲ 32×1 topic
  20. Clinical Outcomes2▲ 16×2 topics
  21. Hippo Pathway2▲ 249×1 topic
  22. Immunogenicity2▲ 76×2 topics
  23. Tumor Targeting2▲ 19×3 topics
  24. YAP/TAZ2▲ 249×1 topic
  25. Monoclonal Antibody2▲ 61×2 topics
  26. NK Cell Recognition2▲ 47×1 topic
  27. Natural Killer Cells2▲ 47×1 topic
  28. Bioanalytical Methods2▲ 150×1 topic
  29. Biosimilars2▲ 150×1 topic
  30. Cetuximab2▲ 35×2 topics
  31. Fluorouracil2▲ 89×1 topic
  32. Gene Therapy2▲ 16×4 topics
  33. Glycosylation2▲ 26×3 topics
  34. KRAS Mutations2▲ 89×1 topic
  35. Cancer Progression2▲ 15×6 topics
  36. Immunity2▲ 6.8×5 topics
  37. PET Imaging2▲ 17×4 topics
  38. Prognostic Factors2▲ 6.3×6 topics
  39. Metastatic2▲ 43×2 topics
  40. Trastuzumab2▲ 56×2 topics

What research is done in Xinghua?

  1. 1 CAR-T cell therapy research Oncology 9 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
  3. 3 Hippo pathway signaling and YAP/TAZ Cell Biology 2 works
  4. 4 Immune Cell Function and Interaction Immunology 2 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 2 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 2 works
  7. 7 HER2/EGFR in Cancer Research Oncology 2 works
  8. 8 Cancer Research and Treatments Biotechnology 1 works
  9. 9 Immunotherapy and Immune Responses Immunology 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works

Research output over time

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more.